15th Annual Multicenter Merkel Interest Group (MMIG) Meeting

March 18, 2021

We will hold the 2021 Multicenter Merkel Interest Group (MMIG) meeting on Friday, June 4th, 11 am-1 pm EDT / 8 am-10 am PDT via Zoom. Please email [email protected] for an invitation with the zoom details. If you have an interesting topic to present, please let us know as we have a few available spots. The tentative agenda is below.

Tentative agenda:

Jürgen Becker, MD/PhD Molecular characterization of classical and variant MCC cell lines (University of Duisburg-Essen)

Natasha Hill, PhD Repurposing disulfiram for the treatment of MCC (National Institutes of Health, Isaac Brownell lab)

Yassi Moshiri, MD MCC Immunotherapy responders after treatment discontinuation: A potentially concerning recurrence rate? (University of Washington, Nghiem lab)

Lisa Zaba, MD/PhD Circulating tumor DNA as a biomarker for MCC tumor burden (Stanford University)

Michael Wong, MD/PhD MDM2 Inhibitor [KRT-232] Therapy in p53 WT MCC Patients Refractory to PD-1/1L Immunotherapy: preliminary results and observations (MD Anderson Cancer Center)

– Review plans for 2nd International MCC Symposium; targeting early 2022